右美托咪定对区域麻醉下非日间骨科手术后谵妄、认知功能障碍及睡眠的影响:一项随机临床试验
本研究为双盲随机对照试验,纳入80例在区域麻醉下接受大型下肢骨科手术的老年患者,比较右美托咪定与丙泊酚镇静的效果。结果显示右美托咪定组术后谵妄、苏醒期谵妄和早期术后认知功能障碍发生率显著低于丙泊酚组,并改善术后即时睡眠质量和3个月时慢性疼痛评分。
要点
- 右美托咪定镇静显著降低术后谵妄、苏醒期谵妄和早期认知功能障碍发生率。
- 右美托咪定改善术后即时睡眠质量并降低3个月时慢性疼痛评分。
- 右美托咪定组术中心动过缓、血流动力学不稳定及一例气道梗阻更常见。
核心结论
- 区域麻醉下大型择期下肢骨科手术老年患者,右美托咪定镇静较丙泊酚显著降低术后谵妄、苏醒期谵妄和早期术后认知功能障碍发生率。
- 右美托咪定还改善患者自报的术后睡眠质量并降低3个月时慢性疼痛评分。
研究设计与样本
- 双盲随机对照试验,纳入80例在区域麻醉下接受大型下肢骨科手术的患者,按1:1随机接受右美托咪定或丙泊酚镇静,右美托咪定组41例,全部完成随访。
- 术后谵妄采用Confusion Assessment Method评估,苏醒期谵妄采用Riker Sedation-Agitation量表评估,术后认知功能障碍采用欧洲心理测量成套测验评估。
- 睡眠质量采用Pittsburg睡眠质量指数评估,慢性疼痛采用painDETECT工具评估,评估时间点为术前、术后48小时和术后3个月。
主要发现
- 术后谵妄发生率右美托咪定组4.8% vs 丙泊酚组38.4%,P = .001。
- 苏醒期谵妄发生率右美托咪定组2.4% vs 丙泊酚组38.4%,P < .001。
- 早期术后认知功能障碍发生率右美托咪定组2.4% vs 丙泊酚组56.4%,P < .001。
- 术后即时睡眠质量PSQI评分右美托咪定组4.4 ± 0.7 vs 丙泊酚组13.4 ± 0.8,P < .001。
- 3个月时painDETECT评分右美托咪定组2.4 ± 0.9 vs 丙泊酚组5.3 ± 0.9,P = .023。
临床怎么用
- 对区域麻醉下大型下肢骨科手术的老年患者,可考虑选用右美托咪定镇静以降低术后谵妄、苏醒期谵妄和早期认知功能障碍风险。
- 右美托咪定镇静可能改善术后即时睡眠质量并减轻3个月时慢性疼痛评分。
- 使用右美托咪定期间需警惕术中心动过缓、血流动力学不稳定及气道梗阻的发生。
局限性
- 术中心动过缓及血流动力学不稳定事件在右美托咪定组更常见。
- 右美托咪定组有1例患者出现气道梗阻(2.4% vs 30.8%,P = .002)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative delirium (POD), emergence delirium (ED), and postoperative cognitive dysfunction (POCD) are disorders of the neuropsychiatric spectrum affecting the elderly during the postoperative period, potentially sharing a common pathophysiological pathway. Disrupted sleep postoperatively correlates with both POD and POCD, revealing overlapping risk factors. This study investigates the potential of dexmedetomidine anesthesia to reduce the incidence of POD (primary outcome), ED, POCD, impairment of sleep quality, and emergent chronic pain (secondary outcomes) in older adults undergoing major orthopedic surgery under regional anesthesia. METHODS: In this double-blind randomized control trial, patients scheduled for major lower limb orthopedic surgery under regional anesthesia were randomized to receive either dexmedetomidine or propofol for sedation at a 1:1 ratio. POD, ED, and POCD were assessed with the Confusion Assessment Method tool, the Riker Sedation-Agitation scale, and the European Battery of psychometric tests, respectively. Sleep quality was assessed using the Pittsburg Sleep Quality Index and chronic pain with the painDETECT tool. Assessments of all outcome variables were performed before surgery, and at 48 hours and 3 months postoperatively. RESULTS: A total of 80 patients (dexmedetomidine group n = 41) were enrolled in the study and completed the follow-up. POD, ED, and early POCD incidence were significantly lower in dexmedetomidine compared to propofol group (4.8% vs 38.4%, P = .001; 2.4% vs 38.4%, P < .001; 2.4% vs 56.4%, P < .001, respectively). Patients in the dexmedetomidine group reported improved sleep quality in the immediate postoperative period (lower PSQI score) and lower painDETECT scores at 3 months (4.4 ± 0.7 vs 13.4 ± 0.8, P < .001; 2.4 ± 0.9 vs 5.3 ± 0.9, P = .023, respectively). Intraoperative bradycardia and hemodynamic instability episodes were more common in the dexmedetomidine group while a single patient presented airway obstruction (2.4% vs 30.8%, P = .002) in the dexmedetomidine group. CONCLUSIONS: Sedation with dexmedetomidine resulted in a statistically and clinically important reduction in the incidence of POD, ED, and early POCD, while it improved self-reported postoperative sleep quality and reduced chronic pain scores in patients undergoing major elective lower limb surgery under regional anesthesia.
引用
- Karageorgos V, Darivianaki P, Spartinou A, et al. A Randomized Clinical Trial of Dexmedetomidine on Delirium, Cognitive Dysfunction, and Sleep After Non-Ambulatory Orthopedic Surgery With Regional Anesthesia. Anesth Analg. 2025. PMID: 40403182. doi:10.1213/ANE.0000000000007548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。